Form 4: Beneficient Director Karen Wendel Acquires Shares and Options

Director Karen Wendel acquired 207,317 shares of Class A common stock and 100,000 stock options in Beneficient on November 21, 2024.

Summary

• Karen Wendel, a director at Beneficient, acquired 207,317 shares of Class A common stock through the settlement of restricted stock units (RSUs) on November 21, 2024.
• These RSUs were granted under the Beneficient 2023 Equity Incentive Plan and will vest in four equal installments over one year.
• Wendel also acquired 100,000 stock options with an exercise price of $0.82 on the same date.
• These options will vest in eight equal installments over two years, also under the 2023 Equity Incentive Plan.
• Both the shares and options are contingent on Wendel's continued service to the company.

Sentiment

Score: 7

Explanation: The document reflects a standard equity grant to a director, which is generally viewed positively as it aligns interests. There are no negative implications.

Positives

• The acquisition of shares and options by a director demonstrates confidence in the company's future.
• The vesting schedules for both the shares and options incentivize long-term commitment from the director.

Risks

• The vesting of the shares and options is contingent on the director's continued service, which introduces a risk of forfeiture if the director leaves the company.
• The value of the shares and options is subject to market fluctuations.

Future Outlook

The vesting schedules for the shares and options suggest a long-term commitment from the director to the company.

Industry Context

This type of equity grant is common practice for incentivizing directors and aligning their interests with those of the shareholders.

Comparison to Industry Standards

• Equity grants to directors are a standard practice across the industry, with vesting schedules typically ranging from one to four years.
• The vesting schedule of one year for the RSUs and two years for the options is within the typical range for such grants.
• The exercise price of $0.82 for the options is a common practice to align the director's interests with the company's performance.

Stakeholder Impact

• The share and option grants to a director can be viewed positively by shareholders as it aligns the director's interests with the company's performance.

Key Dates

Keywords

Beneficient, Karen Wendel, stock options, restricted stock units, equity incentive plan, director, share acquisition, vesting